Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$0.83
-$0.03-3.49%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.70% | 53.30% | -23.53% | 28.07% | -25.47% |
| Total Depreciation and Amortization | 3.05% | -3.26% | 1.24% | 8.41% | -0.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.98% | -27.22% | 521.76% | -80.37% | 100.15% |
| Change in Net Operating Assets | 57.26% | -318.50% | 446.48% | 33.45% | 73.75% |
| Cash from Operations | 272.91% | -118.45% | 190.14% | -9.49% | 453.32% |
| Capital Expenditure | -7.81% | 48.12% | -74.91% | -58.12% | 14.48% |
| Sale of Property, Plant, and Equipment | 5,282.91% | -86.99% | 6,503.13% | -95.76% | -- |
| Cash Acquisitions | -1,204.02% | 97.10% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 119.51% | 265.54% | -7.71% | -124.14% | -158.25% |
| Cash from Investing | 181.48% | 88.81% | -138.82% | -75.15% | -53.90% |
| Total Debt Issued | -46.92% | 87.67% | -45.02% | -52.11% | 182.35% |
| Total Debt Repaid | -32.32% | -59.93% | 55.98% | 52.49% | -498.79% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 82.35% | 98.55% | -6,250.73% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.24% | -1.11% | 49.17% | -- | 100.00% |
| Other Financing Activities | -0.20% | 9.15% | -1.08% | 2.67% | 10.83% |
| Cash from Financing | -881.13% | 146.86% | 57.14% | -439.82% | 353.37% |
| Foreign Exchange rate Adjustments | 184.77% | 30.52% | -4.00% | 45.30% | -766.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.86% | -138.82% | 341.46% | -161.18% | 321.04% |